HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Osteoclast differentiation and activation].

Abstract
In autoimmune arthritis, activation of T cells induces bone destruction through receptor activator of NF-kappaB ligand (RANKL) . Recent study revealed interleukin-17 (IL-17) -producing helper T cell subset (Th17) , but not IFN-gamma-producing Th1, to be responsible for bone destruction. Here we summarize the current understanding of osteoclast differentiation and activation in the context of osteoimmunology.
AuthorsHiroshi Takayanagi
JournalClinical calcium (Clin Calcium) Vol. 17 Issue 4 Pg. 484-92 (Apr 2007) ISSN: 0917-5857 [Print] Japan
PMID17404476 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Interleukin-17
  • RANK Ligand
Topics
  • Animals
  • Arthritis, Rheumatoid (immunology, pathology)
  • Bone and Bones (immunology, pathology)
  • Cell Differentiation
  • Humans
  • Interleukin-17 (biosynthesis)
  • Lymphocyte Activation
  • Osteoclasts (cytology)
  • RANK Ligand (physiology)
  • Signal Transduction (physiology)
  • T-Lymphocyte Subsets (immunology)
  • T-Lymphocytes, Helper-Inducer (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: